Polymyalgia Rheumatica: The Overnight Stiffness — and the Warning Signs That Protect Sight
PMR seizes the shoulders and hips of people past sixty and melts before low-dose prednisone — then demands a year-long taper and vigilance for giant cell arteritis, the companion that can take sight.
· By Shashank Bhosale
The press does not currently name a clinical reviewer of record. Read about contributor roles and the review process before using health information. Editors & Contributors.
It descends over weeks on people past sixty who were fine before: shoulders and hips so stiff and aching that rising from bed becomes a project, arms cannot fasten a bra or reach a shelf, and mornings are the enemy — stiffness lasting an hour or more before the body grudgingly loosens. Polymyalgia rheumatica is among the most common inflammatory conditions of older age in the rheumatology literature, and among the least publicly known — a gap with consequences, because PMR travels with a companion condition that can take eyesight.
The illness and its almost theatrical treatment response
Blood tests show inflammation running high; strength is technically preserved even as function collapses — a distinction accounts describe as maddening to explain. And then the diagnostic twist the literature leans on: a modest dose of prednisone produces improvement so fast — often within days — that the response itself supports the diagnosis. Patients describe it as resurrection and warn newcomers about the sequel: PMR is a long illness treated with a long, slow steroid taper measured in a year or more, flares punctuate the descent, and the steroid itself demands respect — bones, blood sugar, and, as our prednisone fine print piece details, the adrenal recovery at the end.
The companion every PMR patient must know by name
Giant cell arteritis — inflammation of arteries including those serving the eyes — occurs in a documented minority of PMR patients and is the reason this article exists: a new-quality headache at the temples, scalp tenderness, jaw that tires or cramps when chewing, or any visual disturbance — blurring, double vision, a shade over part of the sight — is treated in the literature as an emergency, because untreated GCA can cost vision permanently and high-dose steroids started promptly protect it. Patients describe being handed this warning as a footnote or not at all; the community's rule is blunt: those symptoms mean same-day medical contact, not a diary entry.
Living the taper
Veterans' accumulated wisdom: reduce slowly and resist racing the schedule; treat flares as information, not failure; guard bones and sleep; and expect the fatigue to outlast the pain — the literature documents quality-of-life effects that deserve naming alongside the inflammation markers. Fifty first-person accounts of exactly that year, taper included, are gathered in Stiff at Dawn: Polymyalgia Rheumatica Stories.
More first-person accounts of autoimmune and inflammatory life live on our Autoimmune Conditions shelf; start with our autoimmune reading guide.
Companion reading, not medical advice. New temple headache, jaw fatigue with chewing, or visual changes in anyone with PMR — or past fifty — warrant same-day medical attention.
The Reading Room publishes personal stories and editorial notes from our press. Everything here is companion reading — never medical advice, diagnosis, or treatment. For guidance about your own health, please speak with a qualified clinician. Read how we collect and edit patient testimony in our Editorial Standards, or meet the press at The Masthead.
If this piece was useful, the volumes below hold fifty full-length accounts from people who have been through it — the part an article can only summarise.
